INS and early-onset autosomal dominant Alzheimer disease: Elevated blood glucose levels in patients with Alzheimer's disease [46] may reflect impaired cerebral glucose uptake or peripheral insulin resistance, both of which are well-documented contributors to Alzheimer's disease pathogenesis and oxidative stress [14,85].